Auna SA Stock Plummets to New 52-Week Low of USD 4.14

Auna SA, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low, trading at USD 4.14 on May 27, 2026. This decline marks a significant downturn for the stock, which has seen a one-year performance of -32.03%, contrasting sharply with the S&P 500's 27.0% gain during the same period. The company's market capitalization stands at USD 383 million, and it currently has a price-to-earnings (P/E) ratio of 7.00. However, Auna SA's return on equity is notably negative, indicating substantial challenges in generating profits relative to shareholder equity. Additionally, the stock's price-to-book ratio is 0.80, suggesting that it is trading below its book value. Despite positive results reported in January, the overall performance metrics indicate a struggle for Auna SA, with profits remaining stagnant. The stock's 52-week high was recorded at USD 6.85, highlighting the significant drop in value over the past year. As the company navigates its current market position, these financial indicators reflect a challenging landscape for Auna SA.